FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361946010> ?p ?o ?g. }

• W4361946010 abstract "<div>Abstract<p><b>Purpose:</b> Targeting mutations leading to PI3K/mTOR/Akt activation are of interest in thyroid cancer. We evaluated the efficacy of everolimus in aggressive, radioactive iodine–refractory (RAIR) thyroid cancer and correlated tumor mutational profiling with response. Exploratory medullary and anaplastic thyroid cancer cohorts were included.</p><p><b>Experimental Design:</b> This single-arm, multi-institutional phase II study was conducted from 2009 to 2013 in patients with incurable RAIR thyroid cancer who had radiographic progression six months prior to enrollment. The primary endpoint was progression-free survival (PFS) with a median follow-up of 31.8 months. The study is closed to enrollment but treatment and follow-up are ongoing. A targeted next-generation sequencing platform was used for mutational analysis.</p><p><b>Results:</b> Thirty-three patients with differentiated thyroid cancer (DTC), 10 with medullary thyroid cancer (MTC), and 7 with anaplastic thyroid cancer (ATC) enrolled. For the DTC cohort, median PFS was 12.9 months (95% CI, 7.3–18.5) with a 2-year PFS of 23.6% (95% CI, 10.5–39.5). Median OS was not reached; 2-year OS was 73.5% (95% CI, 53.8–85.8). Among ATC patients, 1 had a partial response and was progression-free until 17.9 months after study entry and one had disease stability for 26 months, respectively. The genomically profiled cohort enriched for PI3K/mTOR/Akt alterations. <i>PI3K/mTOR/Akt</i>–mutated ATC subgroups appeared to benefit from everolimus. Treatment-related adverse events were as anticipated.</p><p><b>Conclusions:</b> Everolimus has significant antitumor activity in thyroid cancer. While genomic profiling does not currently guide therapeutic selection in thyroid cancer patients, these data have important implications when considering the use of an mTOR inhibitor in an era of precision medicine. <i>Clin Cancer Res; 24(7); 1546–53. ©2018 AACR</i>.</p></div>" @default.
• W4361946010 created "2023-04-05" @default.
• W4361946010 creator A5003838163 @default.
• W4361946010 creator A5004313073 @default.
• W4361946010 creator A5026698479 @default.
• W4361946010 creator A5036287306 @default.
• W4361946010 creator A5036875036 @default.
• W4361946010 creator A5038086555 @default.
• W4361946010 creator A5041365902 @default.
• W4361946010 creator A5046440820 @default.
• W4361946010 creator A5047151049 @default.
• W4361946010 creator A5048675362 @default.
• W4361946010 creator A5052296730 @default.
• W4361946010 creator A5056593987 @default.
• W4361946010 creator A5057906544 @default.
• W4361946010 creator A5072950381 @default.
• W4361946010 creator A5072981073 @default.
• W4361946010 creator A5078033630 @default.
• W4361946010 creator A5080875822 @default.
• W4361946010 creator A5086245221 @default.
• W4361946010 creator A5087680459 @default.
• W4361946010 creator A5089114785 @default.
• W4361946010 creator A5090452503 @default.
• W4361946010 date "2023-03-31" @default.
• W4361946010 modified "2023-10-17" @default.
• W4361946010 title "Data from Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study" @default.
• W4361946010 doi "https://doi.org/10.1158/1078-0432.c.6526016" @default.
• W4361946010 hasPublicationYear "2023" @default.
• W4361946010 type Work @default.
• W4361946010 citedByCount "0" @default.
• W4361946010 crossrefType "posted-content" @default.
• W4361946010 hasAuthorship W4361946010A5003838163 @default.
• W4361946010 hasAuthorship W4361946010A5004313073 @default.
• W4361946010 hasAuthorship W4361946010A5026698479 @default.
• W4361946010 hasAuthorship W4361946010A5036287306 @default.
• W4361946010 hasAuthorship W4361946010A5036875036 @default.
• W4361946010 hasAuthorship W4361946010A5038086555 @default.
• W4361946010 hasAuthorship W4361946010A5041365902 @default.
• W4361946010 hasAuthorship W4361946010A5046440820 @default.
• W4361946010 hasAuthorship W4361946010A5047151049 @default.
• W4361946010 hasAuthorship W4361946010A5048675362 @default.
• W4361946010 hasAuthorship W4361946010A5052296730 @default.
• W4361946010 hasAuthorship W4361946010A5056593987 @default.
• W4361946010 hasAuthorship W4361946010A5057906544 @default.
• W4361946010 hasAuthorship W4361946010A5072950381 @default.
• W4361946010 hasAuthorship W4361946010A5072981073 @default.
• W4361946010 hasAuthorship W4361946010A5078033630 @default.
• W4361946010 hasAuthorship W4361946010A5080875822 @default.
• W4361946010 hasAuthorship W4361946010A5086245221 @default.
• W4361946010 hasAuthorship W4361946010A5087680459 @default.
• W4361946010 hasAuthorship W4361946010A5089114785 @default.
• W4361946010 hasAuthorship W4361946010A5090452503 @default.
• W4361946010 hasConcept C126322002 @default.
• W4361946010 hasConcept C142424586 @default.
• W4361946010 hasConcept C143998085 @default.
• W4361946010 hasConcept C203092338 @default.
• W4361946010 hasConcept C2776694085 @default.
• W4361946010 hasConcept C2779341817 @default.
• W4361946010 hasConcept C2779699572 @default.
• W4361946010 hasConcept C2779761222 @default.
• W4361946010 hasConcept C2779984678 @default.
• W4361946010 hasConcept C2780120053 @default.
• W4361946010 hasConcept C2780256643 @default.
• W4361946010 hasConcept C2780739268 @default.
• W4361946010 hasConcept C2781461381 @default.
• W4361946010 hasConcept C31760486 @default.
• W4361946010 hasConcept C526584372 @default.
• W4361946010 hasConcept C535046627 @default.
• W4361946010 hasConcept C71924100 @default.
• W4361946010 hasConcept C86803240 @default.
• W4361946010 hasConcept C87355193 @default.
• W4361946010 hasConceptScore W4361946010C126322002 @default.
• W4361946010 hasConceptScore W4361946010C142424586 @default.
• W4361946010 hasConceptScore W4361946010C143998085 @default.
• W4361946010 hasConceptScore W4361946010C203092338 @default.
• W4361946010 hasConceptScore W4361946010C2776694085 @default.
• W4361946010 hasConceptScore W4361946010C2779341817 @default.
• W4361946010 hasConceptScore W4361946010C2779699572 @default.
• W4361946010 hasConceptScore W4361946010C2779761222 @default.
• W4361946010 hasConceptScore W4361946010C2779984678 @default.
• W4361946010 hasConceptScore W4361946010C2780120053 @default.
• W4361946010 hasConceptScore W4361946010C2780256643 @default.
• W4361946010 hasConceptScore W4361946010C2780739268 @default.
• W4361946010 hasConceptScore W4361946010C2781461381 @default.
• W4361946010 hasConceptScore W4361946010C31760486 @default.
• W4361946010 hasConceptScore W4361946010C526584372 @default.
• W4361946010 hasConceptScore W4361946010C535046627 @default.
• W4361946010 hasConceptScore W4361946010C71924100 @default.
• W4361946010 hasConceptScore W4361946010C86803240 @default.
• W4361946010 hasConceptScore W4361946010C87355193 @default.
• W4361946010 hasLocation W43619460101 @default.
• W4361946010 hasOpenAccess W4361946010 @default.
• W4361946010 hasPrimaryLocation W43619460101 @default.
• W4361946010 hasRelatedWork W2142421136 @default.
• W4361946010 hasRelatedWork W2167368296 @default.
• W4361946010 hasRelatedWork W2552370831 @default.
• W4361946010 hasRelatedWork W2782390899 @default.
• W4361946010 hasRelatedWork W3179062452 @default.
• W4361946010 hasRelatedWork W3213518883 @default.
• W4361946010 hasRelatedWork W4289323628 @default.

• next